Make a secure online gift to the Center for Autism Research and Treatment at UCLA

News and Announcements from CART

Marian Sigman, Ph.D. 1941-2012 - In Memoriam

Marian Sigman, Ph.D., a valued colleague and friend to many at the Semel Institute at UCLA died on April 30, 2012; she was 70 years old. Marian Sigman was a developmental and child clinical psychologist and Professor Emeritus of Psychiatry and Biobehavioral Sciences and of Psychology.  She was an internationally acclaimed scholar, generous teacher and colleague, and a pioneer in the fields of autism and developmental risk.  Dr. Sigman has left her mark on the field with a rich legacy of significant scientific contributions. Please see attached document below for a copy of a memorial tribute to Dr. Sigman.
UCLA CART's Dr. Shafali Jeste featured in American Academy of Neurology news
Behavioral child neurologist, Shafali Jeste, M.D., was featured recently in the American Academy of Neurology (AAN) news about "Clinical Research Training Fellowship Helps Accelerate Autism Investigations."  Both in the AANnews January 2012 issue, as well as in the CRTF newsletter released this April, Dr. Jeste's progress during her AAN fellowship to her productive research path at the UCLA Center for Autism Research and Treatment (CART) which she joined in 2010, were described. See attached story for details.
CART Pilot Grant funding available - applications due May 7, 2012
The UCLA Center for Autism Research and Treatment (CART) invites applications for pilot grants. APPLICATION DEADLINE: May 7, 2012 (Monday 5 pm) FUNDING AMOUNT: $25,000 per project (direct costs) BUDGET PERIOD: August 1, 2012- July 31, 2013   Please see RFA (attached below) for details including application submission requirements.
UCLA CART 4th Annual Autism Symposium
UCLA CART 4th Annual Autism Symposium LIMITED SEATING -  REGISTER TODAY -  Friday, February 3, 2012  at UCLA NRB Auditorium   UCLA Center for Autism Research and Treatment (CART) 4th Annual Autism Research Symposium "Autism 2012 - Autism Spectrum Disorders: Research Update and Evidence-Based Treatment Models" This full-day continuing education symposium is for physicians, psychiatrists, psychologists, other health professionals, teachers, autism service providers, and any others interested in learning of the latest breakthroughs in research and treatment in autism spectrum disorders (ASD).
Dr. Geschwind Elected to the Institute of Medicine
Two faculty members in the David Geffen School of Medicine – Daniel H. Geschwind, M.D., Ph.D., and Barbara Vickrey, M.D., M.P.H. – have been elected to membership in the Institute of Medicine (IOM) of the National Academy of Sciences. Membership in the Institute of Medicine is one of the highest honors conferred in the Health Sciences in the U.S. and internationally. Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor, departments of neurology, psychiatry and human genetics and director, program in neurogenetics and Center for Autism Research and Treatment, Semel Institute. His studies include the development of novel methods as well as applications to study the normal brain and its disorders using advanced genetic techniques. He has evaluated the genetic aspects of normal language and disorders that affect it such as autism, and has also studied degenerative disorders of the brain such as dementias.